Citations

Showing 10 of 108104 citations.

National trends in Fontan operation and in-hospital outcomes in the USA
Akintoye, Emmanuel , Miranda, William R. , Veldtman, Gruschen , Connolly, Heidi M. , Egbe, Alexander C.

Mayo Clinic

Heart | October 30, 2018 | Volume: 105 | Issue: 9 | Pages: 708-714

10.1136/heartjnl-2018-313680 | PMID 30377261 Get It

Background National prevalence and outcomes of Fontan operation in the USA is unknown. Study objective was to determine trends (temporal change) in the annual volume of Fontan operations, in-hospital mortality, postoperative complications and type of hospital discharge. Methods Review of the Nationwide Inpatient Sample for patients that underwent Fontan operation from 2001 to 2014 using the International Classification of Diseases-Ninth Revision, Clinical Modification procedure code for Fontan operation, that is, 35.94. To evaluate for change in patients’ demographics over the years, we divided the patient population into four groups based on procedure year (2001–2004, 2005–2008, 2009–2011 and 2012–2014). Results An estimated 15 934 Fontan operations were performed in the USA from 2001 to 2014. Median (Q1–Q3) age was 3 (2–4) years and 39.8% were female. Hypoplastic left heart syndrome was the most common (29%) congenital heart disease diagnosis. An estimated 1175 procedures were performed in 2001 and 1340 in 2014, but there was no significant change in the number of procedures per year (p=0.47). There was significant decline in in-hospital mortality from 4.5% (53/1175) in 2001 to 1.1% (15/1340) in 2014 (p=0.009). When we compared event rates between 2001–2004 and 2012–2014 periods, there was significant decline in postoperative cardiac complications (12.6% (459/3640) to 8% (378/4706), p=0.007) and respiratory complications (17.1% (623/3640) to 10.2% (481/4706), p<0.001). However, there was increase in the number of patients discharged to home with healthcare assistance or transferred to another acute care facility (5.8% (211/3640) to 9.4% (443/4706), p=0.01) and inflation-adjusted hospitalisation cost (US$46 978 to US$60 383, p<0.001), but no significant change in length of stay (p=0.73). Conclusion On the average, 1062 Fontan operations are performed annually in the USA with no change in volume of procedures but a decrease in in-hospital mortality and postoperative complications over a 15-year period.
Cardiac implantable electronic devices in adults with tetralogy of Fallot
Egbe, Alexander C. , Miranda, William R. , Madhavan, Malini , Ammash, Naser M., Missula, Venkata, Alotaibi, Mohammed Ayedh Sultan, Fatola, Ayotola , Kothapalli, Srikanth, Connolly, Heidi M. , Missula, Venkata R, Al-Otaibi, Mohammed

Mayo Clinic

Heart | October 30, 2018 | Volume: 105 | Issue: 7 | Pages: 538-544

10.1136/heartjnl-2018-314072 | PMID 30377259 Get It

Background Tachyarrhythmias and bradyarrhythmias affect 20%–50% of adult patients with tetralogy of Fallot (TOF) and some of these patients will require cardiac implantable electronic devices (CIED) such as pacemaker and/or internal cardioverter defibrillator. Methods The Mayo Adult Congenital Heart Disease database was queried for patients with repaired TOF and history of CIED implantation, 1990–2017. The study objectives were: (1) determine the occurrence of device-related complications defined as lead failure, lead recall, device infection and lead thrombus; and (2) determine the occurrence and risk factors for defibrillator shock. Results There were 99 patients (age 46±14 years and 66 (66%) men) with CIED, and the CIEDs were 41 (41%) pacemakers and 73 (73%) defibrillators. Indication for defibrillator implantation was for primary prevention in 28 (38%) and secondary prevention in 45 (62%). Device-related complications occurred in 20 (20%) patients (lead failure 17, lead recall 4, device infection 12 and thrombus 3). Twenty-five per cent of all device infections occurred within 30 days from the time of device generator change. Annualised rates of appropriate and inappropriate shocks were 5.7% and 6.2%, respectively. The use of class III antiarrhythmic drug was protective against defibrillator shock. Conclusion The current study provides useful outcome data to aid patient counselling and clinical decision-making. Further studies are required to explore ways to decrease the risk of postprocedural infection after device generator change, and to determine which patients will benefit from empirical antiarrhythmic therapy as a strategy to decrease incidence of inappropriate defibrillator shock.
Computed tomography angiography evaluation of acute limb ischemia
Wallace, Alex, Saini, Aman , Alzubaidi, Sadeer , Naidu, Sailendra , Knuttinen, Grace , Öklü, Rahmi , Pershad, Yash , Oklu, Rahmi

Mayo Clinic

Vasa | October 30, 2018 | Volume: 48 | Issue: 1 | Pages: 57-64

10.1024/0301-1526/a000759 | PMID 30376423 Get It

Abstract. Acute limb ischemia (ALI), a subclass of critical limb ischemia, is a medical emergency. The cause of ALI is usually thrombotic or embolic in nature, and the specific etiology often dictates the appropriate therapy. While the diagnosis is a clinical with common presenting symptoms, advances in ultrasound, computed tomography, and magnetic resonance technology have impacted the diagnosis and subsequent therapy. In ALI, the time to revascularization is critical and computed tomography angiography (CTA) provides a highly sensitive and specific technique for rapidly identifying occlusions and precisely defining vascular anatomy prior to interventions. In patients with significant renal disease, magnetic resonance angiography with or without contrast provides effective alternatives at the expense of imaging time. Treatment can include a variety of endovascular or surgical interventions, including thromboembolectomy, angioplasty, or bypass. Proper evaluation of the etiology of the ischemia, affected vasculature, and medical history is critical to select appropriate treatment and improve patient outcomes. Here, we examine the presentation, evaluation, and treatment of ALI and the role of CTA in diagnosis and therapy.
Recurrent and De Novo Autoimmune Hepatitis
Czaja, Albert J. , Montaño‐Loza, Aldo J. , Montano-Loza, Aldo J , Stirnimann, Guido , Ebadi, Maryam

Mayo Clinic

Liver Transplantation | October 30, 2018 | Volume: 25 | Issue: 1 | Pages: 152-166

10.1002/lt.25375 | PMID 30375180 Get It

Clinical indications for liver transplantation (LT) in patients with autoimmune hepatitis (AIH) are identical to those of patients with other chronic liver diseases that end in acute or semiacute liver failure, decompensated cirrhosis, or hepatocellular carcinoma. Recurrent disease after LT has been reported in 10%‐50% of patients with AIH, and the frequency of detection is influenced in part by the use of protocol or clinically indicated liver biopsy. De novo AIH connotes the development of AIH in patients transplanted for liver diseases other than AIH, and it has been reported in 5%‐10% of pediatric and 1%‐2% of adult recipients. Recurrent disease can negatively impact on graft and patient survival, and retransplantation has been required in 8%‐23%. De novo AIH is within the spectrum of graft dysfunction that includes plasma cell–rich rejection, and it can also progress to cirrhosis and graft failure. Treatment for recurrent or de novo disease is based on the conventional regimens for AIH, and corticosteroid therapy alone or combined with azathioprine is standard. Better control of disease activity prior to LT has been associated with less recurrence, and maintenance corticosteroid treatment after LT can reduce its frequency. In conclusion, recurrent AIH is far more frequent than de novo AIH. Both may have negative impacts on graft and patient survival, and early detection and treatment are key objectives. Future investigations must codify the diagnostic criteria for each graft dysfunction, seek diagnostic biomarkers, and evaluate treatments that improve outcomes without increasing the risk of pre‐ and post‐LT infections.
Organ blood flow and O2 transport during hypothermia (27°C) and rewarming in a pig model
Valkov, Sergei, Mohyuddin, Rizwan, Nilsen, Jan Harald, Schanche, Torstein , Kondratiev, Timofei, Sieck, Gary C. , Tveita, Torkjel , Sieck, Gary

Mayo Clinic

Experimental Physiology | October 30, 2018 | Volume: 104 | Issue: 1 | Pages: 50-60

10.1113/ep087205 | PMID 30375081 Get It

New Findings What is the central question of this study? Absence of hypothermia‐induced cardiac arrest is a strong predictor for a favourable outcome after rewarming. Nevertheless, detailed knowledge of preferences in organ blood flow during rewarming with spontaneous circulation is largely unknown. What is the main finding and its importance? In a porcine model of accidental hypothermia, we find, despite a significantly reduced cardiac output during rewarming, normal blood flow and O2 supply in vital organs owing to patency of adequate physiological compensatory responses. In critical care medicine, active rewarming must aim at supporting the spontaneous circulation and maintaining spontaneous autonomous vascular control. AbstractThe absence of hypothermia‐induced cardiac arrest is one of the strongest predictors for a favourable outcome after rewarming from accidental hypothermia. We studied temperature‐dependent changes in organ blood flow and O2 delivery () in a porcine model with spontaneous circulation during 3 h of hypothermia at 27°C followed by rewarming. Anaesthetized pigs (n = 16, weighing 20–29 kg) were randomly assigned to one of two groups: (i) hypothermia/rewarming (n = 10), immersion cooled to 27°C and maintained for 3 h before being rewarmed by pleural lavage; and (ii) time‐matched normothermic (38°C) control animals (n = 6), immersed for 6.5 h, the last 2 h with pleural lavage. Regional blood flow was measured using a neutron‐labelled microsphere technique. Simultaneous measurements of and O2 consumption () were made. During hypothermia, there was a reduction in organ blood flow, and . After rewarming, there was a 40% reduction in stroke volume and cardiac output, causing a global reduction in ; nevertheless, blood flow to the brain, heart, stomach and small intestine returned to prehypothermic values. Blood flow in the liver and kidneys was significantly reduced. Cerebral and returned to control values. After hypothermia and rewarming there is a significant lowering of owing to heart failure. However, compensatory mechanisms preserve O2 transport, blood flow and in most organs. Nevertheless, these results indicate that hypothermia‐induced heart failure requires therapeutic intervention.
The Authors’ Reply: Diagnostic accuracy of the McGill thyroid nodule score in pediatric patients: methodological issues
Creo, Ana L. , Alahdab, Fares , Nofal, Alaa Al , Thomas, Kristen B. , Kolbe, Amy B. , Pittock, Siobhán T. , Creo, Ana , Al Nofal, Alaa , Thomas, Kristen, Kolbe, Amy , Pittock, Siobhan , Alahdab, Fares

Mayo Clinic

Clinical Endocrinology | October 30, 2018 | Volume: 90 | Issue: 2 | Pages: 385-385

10.1111/cen.13893 | PMID 30374996 Get It

Isokinetic and isometric shoulder rotation strength in the protracted position: A reliability study
Smith, Jay , Padgett, Denny J., Kotajarvi, Brian R., Eischen, Joseph J.

Mayo Clinic

Isokinetics and Exercise Science | October 30, 2018 | Volume: 9 | Issue: 2-3 | Pages: 119-127

10.3233/ies-2001-0075 Get It

Scapular position has been hypothesized to influence rotator cuff function, but no current methods exist to reliably measure shoulder rotation strength in different scapular positions. The purpose of this study was to develop a reliable technique to measure isokinetic (ISOK) and isometric (ISOM) shoulder rotation strength with the scapula protracted. Ten healthy volunteers(5 male, 5 female, ages 20--41) completed two to three ISOM and five ISOK (90 degrees/second) internal rotation (IR) and external rotation (ER) repetitions in a position of scapular protraction with the shoulder abducted 45 degrees in the scapular plane. Subjects returned 24--72 hours later to repeat testing. All torque measurements in the protracted position exhibited excellent intersession reliability (ICCs > 0.97). Shoulder rotational torque can be measured in the protracted scapula position with excellent reliability using the new technique described. Establishing the reliability of the protracted technique is a necessary prerequisite for the completion of future studies examining quantitative differences in rotational torque generation between the neutral and protracted scapula positions in the functional shoulder position of 45 degrees of scapular plane abduction.
Response to Foks et al. (doi: 10.1089/neu.2018.5979): Why Our Long-Term Functional Prognosis Tools are a Valuable Contribution to the Traumatic Brain Injury Outcome Literature
Šíma, Adam , Hoffman, Jeanne M. , Harrison‐Felix, Cynthia , Agyemang, Amma A. , Stromberg, Katharine, Marwitz, Jennifer H. , Graham, Kristin M. , Merchant, Randall E., Kreutzer, Jeffrey S., Brown, Allen W. , Walker, William C. , Kreutzer, Jeffrey S.

Mayo Clinic

Journal of Neurotrauma | October 30, 2018 | Volume: 36 | Issue: 8 | Pages: 1384-1385

10.1089/neu.2018.6069 | PMID 30375265 Get It

Text Messaging Promoting Physician-Led Brief Intervention Tobacco Cessation: A Before-And-After Study among Physicians in Three Tertiary Hospitals in Nigeria
Odukoya, Oluwakemi Ololade , Faseru, Babalola , Uguru, Nkolika P. , Jamda, Mustapha , Onigbogi, Olanrewaju , James, Oluwafunmilola W , Leischow, Scott J. , Ayo‐Yusuf, Olalekan , Odukoya, Oluwakemi , Uguru, Nkolika , James, Oluwafunmilola , Leischow, Scott

Mayo Clinic

Substance Abuse | October 30, 2018 | Volume: 41 | Issue: 2 | Pages: 186-190

10.1080/08897077.2018.1526844 | PMID 30373478 Get It

Background: Physician-led smoking cessation services are suboptimal in Nigeria. Objectives: This study evaluated a text messaging intervention designed to increase the knowledge and practices of physicians in Nigeria to help smokers quit. Methods: Using a pre-post study design, all physicians ( N = 946) in 3 tertiary care hospitals located in 3 geopolitical zones in Nigeria were sent 2–3 text messages weekly over a 13-week period to create awareness and improve cessation practices using the “Ask, Advise and Refer” (AAR) model. The primary outcomes were the awareness of AAR and the proportion of physicians who offered each of the components of the brief intervention (AAR) to at least half of eligible patients. Secondary outcomes included the attitudes and self-reported effects of the messages on motivation to offer AAR to patients who smoke. Results: Of the 946 eligible respondents, only 165 responded to both the before and after intervention surveys (17.4% participation rate). Participants were more likely to indicate awareness of the AAR approach after the intervention (60%) than before (21.2%). Overall, physicians’ practice of each component of the AAR changed significantly after the intervention ( P < .001; McNemar test). Of the participants, 71.5% reported reading the messages most/all of the time and 84.8% reported that the frequency of the messages was just adequate. Conclusions: A brief and low-cost text messaging intervention to physicians increased the awareness and practice of AAR in those who participated in the study. However, the relatively low participation rate highlights the importance of new research to improve and expand text messaging as an intervention among physicians to help them foster tobacco treatment among their patients.
Age stratification corrects bias in estimated hazard of APOE genotype for Alzheimer's disease
Caselli, Richard J. , Liu, Li

Mayo Clinic

Alzheimer's & Dementia: Translational Research & Clinical Interventions | October 30, 2018 | Volume: 4 | Issue: 1 | Pages: 602-608

10.1016/j.trci.2018.09.006 | PMID 30450407 Get It

Abstract Introduction The apolipoprotein E (APOE) e4 allele is a major genetic risk factor of late‐onset Alzheimer's disease. However, its interaction with two other canonical risk factors, age and sex, is not clear. Previous studies have reported conflicting results on its differential effects in men and women, its association with young‐onset AD before the age of 65 years, and its significance in genetic admixture populations. In these studies, the hazard of the e4 allele was assumed to be constant during aging. However, this hypothesis has not been tested and its violation may lead to significant biases and contribute to such discrepant findings. Methods In a prospective cohort of 4727 subjects, we performed Cox regression analysis of the association of the e4 allele with AD age of onset. We then performed diagnostics on the resulting model and tested if the hazard of the e4 allele violated the assumption of proportionality during aging. We examined whether incorporating age stratifications and time‐dependent coefficients could restore the proportionality. We then validated our findings in four independent cohorts. Results Hazard of the e4 allele for AD was nonproportional. It took a stepwise decline around the age of 80 years for men and around the age of 75 years for women. By stratifying subjects into a younger group and an older group, we detected more consistent effects of the e4 allele across multiple independent cohorts. We also found that the e4 allele was a significant risk factor for young‐onset AD with age of onset before 65 years. Discussion Age compositions of study cohorts can significantly bias the estimated effect of the APOE genotype. Studies of AD should consider hidden age structures among subjects and routinely employ appropriate age and sex stratification strategies or nonparametric modeling in experimental designs and data analysis. Finally, we argue that the e4 allele is a risk factor not only for late‐onset AD but also for young‐onset AD.